Clinical Trials Browser

Phase 1/2 × Afatinib × Classical hematology × Clear all

NCT06648096 2024-11-20

AFAN

Phase 1/2 Recruiting

Classical hematologyHead & Neck

Squamous Cell Carcinoma of Head and Neck, Fanconi Anemia